- Home
- LLAP vs PBYI Comparison
LLAP vs PBYI Comparison
Compare LLAP & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LLAP
- PBYI
- Stock Information
- Founded
- LLAP 2013
- PBYI 2010
- Country
- LLAP United States
- PBYI United States
- Employees
- LLAP N/A
- PBYI N/A
- Industry
- LLAP Military/Government/Technical
- PBYI Biotechnology: Pharmaceutical Preparations
- Sector
- LLAP Industrials
- PBYI Health Care
- Exchange
- LLAP Nasdaq
- PBYI Nasdaq
- Market Cap
- LLAP 165.7M
- PBYI 176.1M
- IPO Year
- LLAP N/A
- PBYI N/A
- Fundamental
- Price
- LLAP $0.24
- PBYI $2.51
- Analyst Decision
- LLAP Buy
- PBYI Strong Buy
- Analyst Count
- LLAP 3
- PBYI 1
- Target Price
- LLAP $2.58
- PBYI $7.00
- AVG Volume (30 Days)
- LLAP 8.7M
- PBYI 352.8K
- Earning Date
- LLAP 11-12-2024
- PBYI 10-31-2024
- Dividend Yield
- LLAP N/A
- PBYI N/A
- EPS Growth
- LLAP N/A
- PBYI N/A
- EPS
- LLAP N/A
- PBYI 0.18
- Revenue
- LLAP $133,107,000.00
- PBYI $219,143,000.00
- Revenue This Year
- LLAP $8.71
- PBYI N/A
- Revenue Next Year
- LLAP $34.59
- PBYI N/A
- P/E Ratio
- LLAP N/A
- PBYI $13.95
- Revenue Growth
- LLAP 10.75
- PBYI N/A
- 52 Week Low
- LLAP $0.23
- PBYI $2.13
- 52 Week High
- LLAP $1.62
- PBYI $7.73
- Technical
- Relative Strength Index (RSI)
- LLAP 26.99
- PBYI 42.40
- Support Level
- LLAP $0.24
- PBYI $2.23
- Resistance Level
- LLAP $0.27
- PBYI $2.42
- Average True Range (ATR)
- LLAP 0.01
- PBYI 0.16
- MACD
- LLAP 0.02
- PBYI 0.03
- Stochastic Oscillator
- LLAP 10.26
- PBYI 59.57
About LLAP Terran Orbital Corporation
Terran Orbital Corp is a manufacturer of satellite products primarily serving the aerospace and defense industries. The company provide end-to-end satellite solutions by combining satellite design, production, launch planning, mission operations, and on-orbit support to meet the needs of our military, civil, and commercial customers. Geographically company operates in United States and Europe. Majority of the revenue is generated from United States.
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.